(IN BRIEF) Roche presented positive phase I/II data for NXT007, its Chugai-engineered bispecific antibody for haemophilia A, at the 2025 ISTH Congress. In the NXTAGE study’s highest-dose cohorts (B-3 and B-4), none of the 30 participants experienced bleeds requiring treatment, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged bispecific antibody, Chugai, clinical development, emicizumab, global supply chain, Haemophilia A, haemostatic normalisation, Hemlibra, ISTH Congress 2025, Levi Garraway, NXT007, NXTAGE study, phase I/II data, Roche, subcutaneous dosing, thromboembolic events
(IN BRIEF) GSK’s marketing authorisation application for linerixibat, an investigational ileal bile acid transporter inhibitor, has been accepted for review by the European Medicines Agency. The submission is supported by GLISTEN Phase III trial data showing that linerixibat rapidly and … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, United Kingdom
Tagged alcohol-related liver disease, bile acid transporter, cholestatic pruritus, chronic hepatitis B, EASL Congress, EMA, European Medicines Agency, FDA, GLISTEN trial, GSK, IBAT inhibitor, itch-related sleep interference, Kaivan Khavandi, linerixibat, Marketing Authorisation Application, MASH, NCT04950127, orphan drug designation, PBC, Phase III, primary biliary cholangitis, UK regulatory review
(IN BRIEF) The CHMP has recommended EU approval of Sarclisa alongside VRd for transplant-eligible NDMM, based on GMMG-HD7 trial results showing superior MRD negativity and PFS compared to VRd alone. This potential label extension would mark Sarclisa’s fourth EU approval … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged ASH 2024, autologous stem cell transplant, bortezomib, CHMP, dexamethasone, European Medicines Agency, GMMG-HD7, isatuximab, Journal of Clinical Oncology, lenalidomide, MRD negativity, Multiple Myeloma, NDMM, phase 3 study, progression-free survival, Sanofi, Sarclisa, transplant-eligible, VRd
(IN BRIEF) At Automatica 2025, TUM researchers present a first-of-its-kind medical robot able to perform remote decompression of life-threatening tension pneumothorax during evacuation flights. Fueled by the European Defence Fund’s €25 million iMEDCAP grant, the system merges ultrasound diagnostics with … Read the full press release
Posted in Artificial Intelligence (AI), Aviation & Aerospace, Education, European Union, Germany, Healthcare, Technology
Tagged Automatica trade fair, AVILUS, Avilus Grille drone, Carolin Müller, chemical agent countermeasures, Christoph Parhofer, European Defence Fund, global evacuation flights, iMEDCAP, intraosseous access, medical robotics, MiMed Rescue Robotics, Peter Biberthaler, remote decompression, Technical University of Munich, tension pneumothorax, Tim Lüth, tourniquet application, Trauma Surgery, ultrasound-guided needle
(ACTUALITÉ EN BREF) Sober.Buzz est une communauté mondiale d’entraide créée par Josh Case, entrepreneur et ancien cadre dirigeant d’ENGIE Amérique du Nord, de Photosol US Renewable Energy et d’Energy Capital Group, qui puise son engagement dans son propre parcours de … Read the full press release
Posted in Apparel, Fashion & Beauty, Entertainment, France, Healthcare, Internet & Online, Media, News, Retail, Society
Tagged abstinence, addiction, addictions, Bitcoin, boutique en ligne, Buzz, communauté mondiale, cryptocurrency, Electricité de France, Energy Capital Group, ENGIE, ENGIE Amérique du Nord, ethereum, fashion, Heidi Case, initiatives philanthropiques, jeton $BUZZ, Josh Case, mental health, Photosol, Photosol US Renewable Energy, podcast, podcast Spreading the Good BUZZ, recovery, santé mentale, Sober, Sober Lifestyle, Sober.Buzz, SoberBuzzToken, Sobriety, Texas, USA
(IN BRIEF) Researchers at The Institute of Cancer Research and Queen Mary University have created EIRAs, a computational assay that predicts how bowel cancer cells evolve resistance to chemotherapy. By monitoring cell populations and applying evolutionary models, the tool differentiates … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged bowel cancer, breast cancer, Cancer Research UK, chemotherapy resistance, colorectal cancer, drug discovery, EIRAs, evolutionary biology, Evolutionary Informed Resistance Assays, Freddie Whiting, genetic mutation, Kristian Helin, Machine Learning, Nature Communications, non-genetic adaptation, ovarian cancer, patent, personalized therapy, Queen Mary University of London, Richard Nichols, The Institute of Cancer Research London, Trevor Graham, Wellcome Trust
(IN BRIEF) Merck has awarded its 2025 North American Advance Biotech Grant to Neoclease, a Boston-based startup developing AI-designed gene-editing therapies for Parkinson’s disease and other monogenic disorders. Neoclease will benefit from Merck’s technologies, contract testing, regulatory guidance, and hands-on … Read the full press release
Posted in Artificial Intelligence (AI), Awards, Business, Financial, Germany, Healthcare, Management, Pharma & Biotech, Science, Technology
Tagged 2025 North American winner, Advance Biotech Grant, AI in biotech, Boston biotech, early-stage biotech support, Emprove program, gene-editing therapies, life sciences innovation, M Lab Collaboration Center, Merck, monogenic diseases, NCX-L2, Neoclease, Parkinson's disease, Sebastian Arana, synthetic biology
(IN BRIEF) The University of Copenhagen, in collaboration with Rigshospitalet, has introduced a clinically validated gene-editing method to identify harmful inherited mutations that raise cancer risk. Developed at the university’s Biotech Research and Innovation Center, the CRISPR-Select technique allows scientists … Read the full press release
Posted in Denmark, Education, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged BRCA2, breast cancer, BRIC, cancer diagnosis, cancer risk, CRISPR-Select, gene editing, genetic testing, genomic medicine, hereditary cancer, Maria Rossing, ovarian cancer, personalized medicine, Rigshospitalet, The Journal of Clinical Investigation, University of Copenhagen, variant classification
Sober.Buzz’s Online Store that includes the Exclusive Inspirational Collection by Heidi Case has Launched. Additionally, the much-anticipated Public Sale of the $BUZZ Token begins October 1st. (IN BRIEF) Sober.Buzz, a global recovery-focused community founded by entrepreneur and recovery advocate Josh … Read the full press release
Posted in Apparel, Fashion & Beauty, Entertainment, Healthcare, Internet & Online, Media, News, Retail, Society
Tagged "Spreading the Good BUZZ" podcast, $BUZZ token, Addication, addiction, addiction struggles, addicts support, alcoholism, Bitcoin, cryptocurrency, Ethereum blockchain, Exclusive Inspirational Collection by Heidi Case, fashion, Guerrilla Marketing Consultants Platinum Podcast, Heidi Case, Josh Case, Josh's Sobriety Independence Day, mental health, podcast, recovery, recovery journeys, Sober Curious, Sober Living, Sober.Buzz, Sober.Buzz online store, Sober.Buzz Podcast, Sobriety, sobriety journey
(IN BRIEF) The University of Glasgow is leading the PHOENIX Study, a landmark clinical trial investigating how genetic testing can personalise prescribing across NHS Scotland. Over 4,000 patients will be recruited across Greater Glasgow and Clyde to explore how DNA … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged adverse drug reactions, Agena Bioscience, DNA testing, genetic testing, Katriona Brooksbank, Living Laboratory, medication safety, MyDNA, NHS Greater Glasgow and Clyde, NHS prescribing, personalised medicine, PGx, pharmacogenomics, PHOENIX Study, precision healthcare, Queen Elizabeth University Hospital, Sandosh Padmanabhan, University of Glasgow, West of Scotland Innovation Hub
(IN BRIEF) From its leadership of key work packages to its rich data resources—the ESC Atlas of Cardiology and GRASP study—the European Society of Cardiology is driving EuroHeartPath’s mission to transform heart-disease care in Europe. This €27 million Horizon Europe … Read the full press release
Posted in Artificial Intelligence (AI), European Union, France, Healthcare, Netherlands, Society, Technology
Tagged AI machine learning, cardiovascular care pathways, data harmonization, digital health, dissemination, ESC Atlas of Cardiology, EuroHeartPath, European Society of Cardiology, EXPLAIN, GRASP program, Health Equity, Horizon Europe, IHI-JU, PACEVALUE, pathfinder studies, patient-centred care, point-of-care testing, policy recommendations, robotics, WP2, WP3, WP4, WP6, WP8, WP9
(IN BRIEF) The EIB is extending €235 million in loans to enhance public services in Finland’s Uusimaa region: €135 million for upgrading three major hospitals under Helsinki University Hospital’s broader €300 million program, and €100 million for building and refurbishing … Read the full press release
Posted in Banks, Education, European Union, Financial, Finland, Healthcare, Investment
Tagged educational facilities, EIB, energy efficiency, European Investment Bank, Finland investments, healthcare modernization, Helsinki University Hospital, HUS, Jari Finnilä, Jorvi Hospital, Meilahti Hospital, Peijas Hospital, Pekka Timonen, public services, sustainable infrastructure, Thomas Östros, Uusimaa, Vantaa schools
(IN BRIEF) BioNTech agreed to buy CureVac in an all-stock deal valuing CureVac at ~$1.25 billion, exchanging each share for $5.46 in BioNTech ADSs—a 55% premium to its recent stock price. The merger, expected to close in 2025, strengthens BioNTech’s … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged 2025 closing, ADSs, Alexander Zehnder, all-stock acquisition, American depositary shares, BioNTech, BNT327, Cancer Immunotherapy, CureVac, delivery formulations, dievini Hopp BioTech, integration plan, KfW, merger premium, mRNA, mRNA manufacturing, oncology strategy, pan-tumor programs, partnership, regulatory approvals, transformational therapies, Tübingen subsidiary, Ugur Sahin
(IN BRIEF) Boehringer Ingelheim and Eko Health have partnered to launch a canine-specific heart murmur detection solution in 2026. Leveraging Boehringer’s veterinary cardiology insights and proprietary algorithm alongside Eko’s AI-enabled digital stethoscopes and mobile app, the tool will help veterinarians … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI algorithm, Boehringer Ingelheim, canine cardiology, Connor Landgraf, digital stethoscope, Dr. Erich Schött, early diagnosis, Eko Health, heart murmur detection, MMVD, mobile app, myxomatous mitral valve disease, partnership, pet health, veterinary innovation
(IN BRIEF) TUM and TUM University Hospital have been awarded $1.5 million by Google.org to create AIdvice, an AI-powered chatbot that provides cancer patients and medical professionals with reliable, personalized information. Built around a bespoke guidelines database, AIdvice will use … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Environment, Financial, Germany, Healthcare, Industrial, Internet & Online, Investment, Management, Marketing, News, Science, Technology
Tagged AI hallucinations, AIdvice, cancer information, clinical pilot, data protection, Dr Jan Peeken, evidence-based answers, Florian Matthes, Google.org Accelerator: Generative AI, knowledge database, Large Language Model, Munich Data Science Institute, partnership, Radiation Oncology and Radiotherapy, source attribution, sustainability, Technical University of Munich, TUM University Hospital
(IN BRIEF) EQT Life Sciences has led a Series A investment in Mosanna Therapeutics to advance its lead drug candidate, MOS118—a nasal spray designed to treat obstructive sleep apnea—into Phase 2 trials. Co-investors include Pivotal bioVenture Partners, Forbion, Norwest, and … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Sweden, Switzerland, Technology
Tagged airway reflex restoration, Basel, biotech funding, Daniela Begolo, David Weber, EQT Life Sciences, Forbion, Forty51 Ventures, HTGF, MOS118, Mosanna Therapeutics, nasal spray therapy, neurological treatment, non-invasive sleep apnea therapy, Norwest, obstructive sleep apnea, OSA treatment, partnership, Phase 2 clinical trial, Pivotal bioVenture Partners, Redwood City, Supermoon Capital, sustainability
(IN BRIEF) Wolters Kluwer Health has announced comprehensive updates to its Sentri7 Drug Diversion and Sentri7 Pharmacy solutions, enhancing medication safety and compliance workflows for healthcare teams. The upgraded tools feature more intuitive user interfaces, improved risk scoring, enhanced documentation, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Netherlands, News, Technology
Tagged artificial intelligence in healthcare, clinical workflows, cost savings, digital health, Drug Diversion, healthcare compliance, Healthcare Innovation, HEAT score, hospital pharmacy tools, Karen Kobelski, KLAS Research, medication management, medication safety, nursing workflows, opioid crisis, patient safety, pharmacy surveillance, risk management, Sentri7, Sentri7 Pharmacy, Wolters Kluwer
(IN BRIEF) Sanofi has launched early global shipments of Beyfortus (nirsevimab) in anticipation of the 2025–2026 RSV season, enabling healthcare providers to begin immunizations well before the typical onset of infections in November. In collaboration with AstraZeneca, Sanofi has significantly … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged AstraZeneca, Beyfortus, EU label, extended protection, global distribution, hospitalizations, infant immunization, lower respiratory tract disease, monoclonal antibody, newborn care, nirsevimab, pediatric health, public health, real-world studies, respiratory syncytial virus, RSV, RSV season, Sanofi, Thomas Triomphe, Vaccine Innovation, vaccine supply chain
(IN BRIEF) At the 10th Open Meeting of the Spanish Network of Healthy Companies, Sener was recognized for its Sener Care programme and commitment to promoting workplace health. The award highlights Sener’s comprehensive health initiatives, including disease prevention, psychological support, … Read the full press release
Posted in Awards, Business, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Media, News, Spain, Technology
Tagged ADIF, Awards, Castilla-La Mancha, corporate health, disease prevention, Employee Wellbeing, health initiatives, healthy lifestyle habits, HSE, INSST, leadership, psychological support, Renfe, Sacyr, SENER, Sener Care, Spanish Heart Foundation, Spanish Network of Healthy Companies, workplace health, workplace safety
(IN BRIEF) AstraZeneca’s Calquence, in combination with venetoclax, with or without obinutuzumab, has been approved by the European Commission for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL). The approval follows the positive results from the … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AMPLIFY Phase III trial, AstraZeneca, Barbara Eichhorst, BTK inhibitor, Calquence, chemoimmunotherapy, chronic lymphocytic leukaemia, clinical trial, CLL, Dave Fredrickson, European Commission approval, European Union, fixed-duration regimen, hematologic diseases, hematology, leukemia, obinutuzumab, oncology, progression-free survival, treatment option, venetoclax
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?